chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed pustular rash on chest on the second day following vaccination. No fever or constitutional symptoms.  Rash with evidence of improvement on third day post vaccination.  Innoculation site with 2-3mm area of induration/erythema on day 3.
On June 19th I had a cough and diarrhea for two days.  Tuesday I had a really sore throat and it lasted for 3 days.  By Friday I got the monoclonal antibodies and began to feel better.  The only symptom that are persistent are the couch, deep from the chest.   Tested positive that week.
Mom states child broke out in a rash that looked ling ringworm.  Patient has round lesions and a lot of pin print lesions all over trunk, back, arms, neck, legs.  Has large lesions on the L leg.  Some of the lesions look like they are drying.  Mom states she  is using lamosil powder and magnesium in the PM.
No adverse events-- patient lied and indicated she was 18 years of age. She lied about her age on online form, lied about her age when signing the consent waiver, lied about her age to registration staff, lied about her age to vaccinators and to PH when called for a follow-up to clarify DOB.
Narrative:  Patient with comorbidities including asthma (on omalizumab), HTN, HLD, DM2, and BPH who presents with worsening dyspnea. He completed both doses of the Moderna vaccine. His symptoms started 7/19 and included cough, fatigue, body aches, diarrhea, nausea, and dyspnea. Was tested positive for COVID on 7/23. He lives with his wife, who got tested and was negative. He is not sure where he contracted the virus. Patient did not require O2
This is a spontaneous report from a contactable consumer. A 4-month-old female patient received the second dose of PREVNAR 13 (Suspension for injection; NDC number: 0005-1971-01, lot number: W33491, expiry date: Jun2020) at the age of 2 months, intramuscularly on 03Oct2018 at 0.5 mg, single for immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of PREVNAR 13 on an unspecified date for immunisation. On 05Dec2018, the patient experienced high fever, nausea, and vomiting. It was reported that the patient had a possible adverse reactions of high fever and vomiting with pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein). It was reported that the product was directly ordered from Merck Vaccines, further reported as ordered directly from MerckVaccines.com. It was reported that the parents took the patient to the ER that night and the ER gave her TYLENOL suppository (treatment) and also ondansetron (treatment) for the nausea and vomiting. The outcome of the events was recovered on an unspecified date in Dec2018. The patient is completely better now.
Apprx. 10 min after receiving vaccines. Hep A (peds), Typhoid, MENVEO, and Influenza pt c/o vision change (seeing black) and ringing in the ears. Symptoms lasting less than one minute.
Fever , shortness of breath , Fatigue , kidney pain, UTI , irregular cycle , body aches. 3 rounds of antibiotics
8" long by 2" wide bright red-hot from elbow area down arm, c/o severe itching;c/o knees tender-t99;red dots on arm x 3 dasy, swelling & welting;dx allergic rxn;
PPSV23 vaccine to left deltoid on 2-13-17. Swelling and pain began that day with relief of swelling over next 2 days but called on 3-2-17 to report arm is still painful with some movements. Encouraged to have evaluated by her primary physician.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.  The patient's past medical history included Anxiety and Depression.  On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On 14-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In August 2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.     No concomitant medication information was reported. No treatment medication information was reported. In Jun-2021, the patient experienced exacerbation of anxiety and depression and in Aug-2021, the patient experienced fever. Patient had Electrical stimulation therapy. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-624195.
Information has been received from a company representative concerning a female with epilepsy, who was vaccinated with the first dose of Gardasil vaccine at approximately 2 PM. Concomitant therapy included Carbatrol and Focalin for epilepsy. Subsequently around 2AM, the patient had an urge to diarrhea and throw up, but never did. Her mom later found her passed out on the floor. No further information provided. Additional information has been requested.
Headache, Myalgia, Fever, Rash, Diarrhea, NauseaVomiting, chills fatige site pain Narrative:
Subsequent to receiving Engerix B, the pt experienced redness, itching and warmth in her arms. She did not have shortness of breath. No treatment was given. Symptoms resolved in three days. As of 08/10/2000, the outcome of the event is resolved.
No adverse effects were reported; Patients were administered improperly stored vaccines doses; This spontaneous report was received from a registered nurse, concerning a patient of unspecified age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On 16-APR-2019, the patient was vaccinated with improperly storage doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis, lot #R034700 and expiration date 16-JUN-2020 (strength, dose, frequency and route of administration were not reported); with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis, lot #R033080 and expiration date 06-JUN-2020 (strength, dose, frequency and route of administration were not reported); and with hepatitis a vaccine, inactivated (VAQTA) for prophylaxis lot #S001485, expiration date 12-MAY-2020 and lot #R012988 and expiration date 30-MAY-2019. No adverse effects were reported.   The temperature excursion was reported as below 36°F (35.4°F) during a time frame of 27 minutes. Previous temperature excursion was reported as below 36°F (35.4°F) during a time frame of 15 minutes.   A digital data logger was involved.   This is one of several reports received from the same  reporter.; Sender's Comments:  US-009507513-1904USA012221: US-009507513-1905USA002744: US-009507513-1905USA002745: US-009507513-1905USA002746: US-009507513-1905USA002747: US-009507513-1905USA002748: US-009507513-1905USA002749: US-009507513-1905USA002750: US-009507513-1905USA002751: US-009507513-1905USA002752: US-009507513-1905USA002753: US-009507513-1905USA002754: US-009507513-1905USA002755: US-009507513-1905USA002756: US-009507513-1905USA002757: US-009507513-1905USA002758: US-009507513-1905USA002759: US-009507513-1905USA002760: US-009507513-1905USA002761: US-009507513-1905USA002762: US-009507513-1905USA002763: US-009507513-1905USA002765: US-009507513-1905USA002766: US-009507513-1905USA002767: US-009507513-1905USA002768: US-009507513-1905USA002769: US-009507513-1905USA002770:
Throat tightness; This spontaneous case was reported by a nurse and describes the occurrence of THROAT TIGHTNESS (Throat tightness) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced THROAT TIGHTNESS (Throat tightness). On 19-Mar-2021, THROAT TIGHTNESS (Throat tightness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. No treatment was reported.
RASH IN NECK AND BETWEEN MY HANDS, MIGRAINE, BLOOD PRESURE, JOINT PAIN.
Temp increased 104.5 after vaccines per mom. Afebrile now "red" spots on (R) leg. No treatment given. Cool compress prn.
Pt. received MCV4 and VARIVAX today 10/14/08: after about 2 sec., pt. started with seizures and incontinence. I quickly took control of the situation and gave her 0.3 ml Ammonia inhalant, raised pt. foot and called RN as well as Dr. Pt. reacted well w/Ammonia. Pt. was seen w/provider and sent to ER.
At 5:51 pm on Friday night, I was standing at the kitchen sink hand-washing dishes before work and my left arm suddenly experienced complete paralysis and dropped into the sink. I could not move, lift or feel my left arm at all (from my shoulder all they way to my fingertips). At the same time that my left arm felt paralyzed, I felt left-sided scalp and facial tingling and experienced slurred speech. After my first word slurred, I was unable to talk completely. I had aphasia (I could think clearly, but could not speak at all). Complete loss of speech lasted for about 1 minute. When my speech returned I was able to very slightly move my left arm again, but could not grip anything/no fine motor skills. I could not change my clothes, tie my shoes, etc. I was able to dial a neighbor with my right hand to take me to the emergency department. I was evaluated by neurology in the ED around 6:40 pm.
per pt caseworker: pt c/o chest pain within about 1 hr post vaccinations but resolved spontaneously.  The night following vaccinations pt reported chills, fever (103.5 F), H/A, body aches, and blurred vision.   No reports of rash, swelling, or difficulty breathing.  Caseworker reported taking pt to ED for care.  Pt discharge 8/12/19 on oral antibiotics and iron pills.  Pt rec'd blood transfusion during course of stay due to low hemoglobin per caseworker report.
Information has been received from a consumer concerning her 11 month old son with mild nose congestion and a history of jaundice and phototherapy at birth who on 21-SEP-2007 was vaccinated intramuscularly into the right leg with a second dose of Comvax (Lot #656519/0259U). Concomitant suspect vaccination on the same day included ProQuad. Other concomitant vaccination on the same day included DTaP. On 01-OCT-2007, ten days post vaccination, the mother reported that the patient developed a slight rash on the abdomen. On 02-OCT-2007, day 11 the patient developed a fever of 99.9 axillary with rash becoming raised and spreading over the face, chest, back arms and legs. The rash became slightly itchy. "Doctor consulted since Dr. out, and mother informed it was probably MMR reaction which could require supportive care and close monitoring". The mother was told to take child to urgent care if symptoms escalated or the emergency room if any life threatening signs or symptoms developed. The mother was advised to use BENADRYL if itching was a problem. The child was not experiencing any other problems and was eating and playing normally. At the time of the report the patient's outcome was unknown. No further information is available.
During the injection pharmacist said, 'oops I slipped". Went home, arm was sore I took TYLENOL, at 1:30AM I woke up in pain, I went to look up my reactions and I couldn't read, I was confused and went to the ER and was out of it, felt like I was going to throw up. Was prescribed tremetol. Muscle sore but not as bad. I was really confused. My first and second vaccines I had no reactions.
Systemic: Chills-Medium, Systemic: Confusion-Severe, Systemic: Diarrhea-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Weakness-Severe
Flu like symptoms, chills, achy body.  Took Advil, drank fluids, rested.
1st vaccination a week ago and started breaking or in hives about 3 days ago; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (1st vaccination a week ago and started breaking or in hives about 3 days ago) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (1st vaccination a week ago and started breaking or in hives about 3 days ago). At the time of the report, URTICARIA (1st vaccination a week ago and started breaking or in hives about 3 days ago) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Area of administration is red, swollen and warm. Big red patch is visible on upper left arm.
HEAD HURTS; FIRE SHOT DOWN ARM TO ELBOW WHEN RECEIVED THE VACCINE; SORE AND ACHY FEELING/ SORENESS EVERYWHERE; FEELS LIKE CRAP; SENSITIVE TO LIGHT; FEVER OF 102.5; This spontaneous report received from a parent concerned a 21 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A2119 or 201A211A) dose was not reported, administered on 08-APR-2021 10:50 on right arm for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced sore and achy feeling/ soreness everywhere. On 08-APR-2021, the subject experienced feels like crap. On 08-APR-2021, the subject experienced sensitive to light. On 08-APR-2021, the subject experienced fever of 102.5. On 08-APR-2021, the subject experienced fire shot down arm to elbow when received the vaccine. Laboratory data included: Body temperature (NR: not provided) 102.5 F. On 08-APR-2021 17:30, the subject experienced head hurts. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fire shot down arm to elbow when received the vaccine, was recovering from fever of 102.5, and sensitive to light, and had not recovered from sore and achy feeling/ soreness everywhere, feels like crap, and head hurts. This report was non-serious.
Received vaccine Oct 9th states. Approx 5 days later started with few "pimple like" hives that itch-continue to spread at present are on leg, groin-took Benadryl with No Relief
Shingles outbreak began R back at lower scapula on 12/14/07, extends unilaterally around body covering R outer side of breast.  L eye lower L outer corner involvement.  12/16 07 3-4 pustules noted today.  12/18/07 clear sclera.  Back lesions varying stages of development, large blisters dime sized, red pustules large to pencil lead size approx 5 inch wide band.  Acyclovir 800 mg Tid and ophthalmology referral.
Placed in refrigerator on 08-Oct-2021, Vaccine expired on 03-Oct-2021 and administered on 08-Oct-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Placed in refrigerator on 08-Oct-2021, Vaccine expired on 03-Oct-2021 and administered on 08-Oct-2021) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Placed in refrigerator on 08-Oct-2021, Vaccine expired on 03-Oct-2021 and administered on 08-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Placed in refrigerator on 08-Oct-2021, Vaccine expired on 03-Oct-2021 and administered on 08-Oct-2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No adverse event was reported. The vial had not undergone any temperature excursion issue. The vial was initially placed in the refrigerator on 08-Oct-2021. No treatment information was provided.
Fever (103.4), Body aches and chills Recommendation: Continue to monitor fever, she jut took tylenol. If fever continues please call your PCP or go to the nearest ER
pt recv vax 26OCT97 & pt devel varicella vesicles;
sore arm; Stress will bring on her migraine headaches, and that she could not tell the difference between the effects of the vaccine or one of her migraines; Stress will bring on her migraine headaches; Headache, lasting longer than a week; Missed second shot due to an overpowering migraine headache / then rescheduled; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MIGRAINE (Stress will bring on her migraine headaches, and that she could not tell the difference between the effects of the vaccine or one of her migraines), STRESS (Stress will bring on her migraine headaches), HEADACHE (Headache, lasting longer than a week) and INTENTIONAL PRODUCT USE ISSUE (Missed second shot due to an overpowering migraine headache / then rescheduled) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004CC1A and 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included TRAMADOL and AMITRIPTYLINE for Migraine, ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), MIGRAINE (Stress will bring on her migraine headaches, and that she could not tell the difference between the effects of the vaccine or one of her migraines), STRESS (Stress will bring on her migraine headaches), HEADACHE (Headache, lasting longer than a week) and INTENTIONAL PRODUCT USE ISSUE (Missed second shot due to an overpowering migraine headache / then rescheduled). On 30-Apr-2021, INTENTIONAL PRODUCT USE ISSUE (Missed second shot due to an overpowering migraine headache / then rescheduled) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache, lasting longer than a week) had not resolved and MIGRAINE (Stress will bring on her migraine headaches, and that she could not tell the difference between the effects of the vaccine or one of her migraines) and STRESS (Stress will bring on her migraine headaches) outcome was unknown.            Patient was using aspirin for anti platelet medication.  The patient took tramadol and amitriptyline for migraine headaches.   This case was linked to MOD-2021-090200 (Patient Link).
4 mo. old breastfed 50%/Enfamil formula 50% baby with GER (but "happy spitter") who developed moderately large amount of hematemesis 3 hrs. after rotavirus vaccine. Endoscopy nl and Abd U/S nl next day.
Information has been received from a registered nurse concerning an 11 year old female patient who "one or two months ago" approximately in March 2010, received a second adult dose of VAQTA (Lot # 666802/1684Y). The child's mother noted that on a computer generated record it said that the child received a dose of GARDASIL (Lot # 662304/1013Y) but on the hand written medical legal record it was recorded as VAQTA (Lot # not recorded on the chart). No adverse reaction was noted. The first dose of VAQTA was given on 02-SEP-2005. The patient sought unspecified medical attention. Follow up information has been received from the registered nurse who reported that the medical assistant was 95% sure she gave the patient a dose of pediatric VAQTA and that there was a clerical error in which HPV vaccine printed out on the record. It was reported that the parent wanted to be 100 percent sure her child did not receive GARDASIL but there were no commercially available test for this. Also since this would have been the second dose of VAQTA it would be pointless to run hepatitis A antibody testing. There was no adverse reaction in this case. No further information is available.
DIDN'T RECEIVE THE FULL DOSE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A expiry: UNKNOWN) dose was not reported, administered on 03-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-MAY-2021, the subject experienced didn't receive the full dose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of didn't receive the full dose was not reported. This report was non-serious.
Administration of Expired Vaccine; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-237427 (Patient Link).
I developed shingles (zoster reactivation) in the lumbar region on the left side. The presentation was back pain which preceded the rash by about 3-5 days. The zoster was radicular, in approximately the high lumbar root area, only on the left. The rash did not come fully around to the abdomen. The back pain was severe for about 1 week but not completely incapacitating.  The rash that eventually developed was classic and vesicular. I went my primary care physician just so that the diagnosis could be verified and the physician agreed that this was zoster. I am a neurologist by background and currently work in R&D at a pharmaceutical company. the time course between the vaccine administration (Jan 26 2019) and the onset of the zoster (around Mar 3 2019) was about 5-6 weeks. The zoster pain and rash resolved on its own; I did not take antiviral therapy.